Literature DB >> 25995285

Lipoprotein lipase and atherosclerosis.

Junji Kobayashi1, Hiroshi Mabuchi2.   

Abstract

Lipoprotein lipase has long been known to hydrolyse triglycerides from triglycerides-rich lipoproteins. More recently, it has been shown to promote the binding of lipoproteins to various lipoprotein receptors. Evidence is also presented regarding the possible atherogenic role of lipoprotein lipase. In theory, lipoprotein lipase deficiency should help to clarify this question. However, the rarity of this condition means that it has not been possible to conduct epidemiological studies. An alternative approach is to investigate the correlation of lipoprotein lipase with onset of cardiovascular disease in prospective studies in large population-based cohorts. Complementary with this approach, animal models have been used to explore the atherogenicity of lipoprotein lipase expressed by macrophages.
© The Author(s) 2015.

Entities:  

Keywords:  Atherosclerosis; lipoprotein lipase

Mesh:

Substances:

Year:  2015        PMID: 25995285     DOI: 10.1177/0004563215590451

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  10 in total

1.  A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase.

Authors:  Kazuya Miyashita; Katsuyuki Nakajima; Isamu Fukamachi; Yuji Muraba; Takafumi Koga; Yohnosuke Shimomura; Tetsuyo Machida; Masami Murakami; Junji Kobayashi
Journal:  J Lipid Res       Date:  2017-06-20       Impact factor: 5.922

2.  Deposition and hydrolysis of serine dipeptide lipids of Bacteroidetes bacteria in human arteries: relationship to atherosclerosis.

Authors:  Reza Nemati; Christopher Dietz; Emily J Anstadt; Jorge Cervantes; Yaling Liu; Floyd E Dewhirst; Robert B Clark; Sydney Finegold; James J Gallagher; Michael B Smith; Xudong Yao; Frank C Nichols
Journal:  J Lipid Res       Date:  2017-08-16       Impact factor: 5.922

3.  Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease.

Authors:  Shobini Jayaraman; Antonio Pérez; Inka Miñambres; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-10-02       Impact factor: 4.698

Review 4.  Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy.

Authors:  Soo Ghee Yeoh; Jia Siang Sum; Jing Yi Lai; W Y Haniff W Isa; Theam Soon Lim
Journal:  J Cardiovasc Transl Res       Date:  2021-08-31       Impact factor: 3.216

5.  ABCA1 and ABCG1 DNA methylation in epicardial adipose tissue of patients with coronary artery disease.

Authors:  Valentina V Miroshnikova; Alexandra A Panteleeva; Irina A Pobozheva; Natalia D Razgildina; Ekaterina A Polyakova; Anton V Markov; Olga D Belyaeva; Olga A Berkovich; Elena I Baranova; Maria S Nazarenko; Valery P Puzyrev; Sofya N Pchelina
Journal:  BMC Cardiovasc Disord       Date:  2021-11-27       Impact factor: 2.298

6.  MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.

Authors:  Wei Xie; Liang Li; Min Zhang; Hai-Peng Cheng; Duo Gong; Yun-Cheng Lv; Feng Yao; Ping-Ping He; Xin-Ping Ouyang; Gang Lan; Dan Liu; Zhen-Wang Zhao; Yu-Lin Tan; Xi-Long Zheng; Wei-Dong Yin; Chao-Ke Tang
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

7.  Duration-response association between exercise and HDL in both male and female Taiwanese adults aged 40 years and above.

Authors:  Cheng-Feng Jan; Hui-Chin Chang; Disline Manli Tantoh; Pei-Hsin Chen; Wen-Hsiu Liu; Jing-Yang Huang; Min-Chen Wu; Yung-Po Liaw
Journal:  Oncotarget       Date:  2017-12-14

8.  Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins.

Authors:  Markus Sällman Almén; Jonas Björk; Ulf Nyman; Veronica Lindström; Magnus Jonsson; Magnus Abrahamson; AnnaLotta Schiller Vestergren; Örjan Lindhe; Gary Franklin; Anders Christensson; Anders Grubb
Journal:  Kidney Int Rep       Date:  2018-09-13

9.  Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.

Authors:  Toshiaki Teratani; Kengo Tomita; Hirotaka Furuhashi; Nao Sugihara; Masaaki Higashiyama; Makoto Nishikawa; Rie Irie; Takeshi Takajo; Akinori Wada; Kazuki Horiuchi; Kenichi Inaba; Yoshinori Hanawa; Naoki Shibuya; Yoshikiyo Okada; Chie Kurihara; Shin Nishii; Akinori Mizoguchi; Hideaki Hozumi; Chikako Watanabe; Shunsuke Komoto; Shigeaki Nagao; Junji Yamamoto; Soichiro Miura; Ryota Hokari; Tananori Kanai
Journal:  Hepatol Commun       Date:  2019-06-06

10.  Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease.

Authors:  Junji Kobayashi
Journal:  J Atheroscler Thromb       Date:  2021-04-01       Impact factor: 4.394

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.